GlobeNewsWire · HCM · October 23, 2026

Lexicon Pharmaceuticals Provides Update on Baseline Patient Characteristics for Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Hypertrophic Cardiomyopathy

Get the app for more

Explore stock news, insights and company research.